Boehringer Ingelheim buys MacroDel platform developer ICD Therapeutics

Boehringer Ingelheim buys MacroDel platform developer ICD Therapeutics

Source: 
Pharmaceutical Business Review
snippet: 

Boehringer Ingelheim has acquired MacroDel biologics-delivery platform developer, ICD Therapeutics, for an undisclosed amount.